Volume 6, Issue 4 (volume 6, number4 2014)                   IJDO 2014, 6(4): 157-162 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Dehghan Banadaki S, Mozaffari-Khosravi H, Ahmadi S, Hajimirzadeh M K, Lotfi M H. Effects of Oral L-Carnitine Supplementation on C-Reactive Protein and Blood Sugar in Hemodialysis Patients: A Randomized Clinical Controlled Trial. IJDO 2014; 6 (4) :157-162
URL: http://ijdo.ssu.ac.ir/article-1-209-en.html
Department of Nutrition, Faculty of Health, Shahid Sadoughi University of Medical Sciences, Yazd, IranYazd Diabetic Research Center, Shahid Sadoughi University of Medical Sciences, Yazd, Iran
Abstract:   (3926 Views)
Objectives: Inflammation is a common complication in patients treated with hemodialysis and increasing in inflammatory factors such as C-reactive Protein (CRP) is associated with increased cardiovascular disease and mortality in these patients. The purpose of this study was to investigate the effect of oral L- carnitine supplementation on serum CRP concentration and fasting blood sugar (FBS) in patients undergoing hemodialysis. Materials and Methods: This study was a randomized clinical trial on 50 patients (30 males and 20 females) undergoing hemodialysis in the age range of 21-84 years from hemodialysis units of Yazd hospitals. Participants randomly divided into two groups, the Carnitine group (CaG) consumed daily oral syrup of L- carnitine containing 1000 mg of Carnitine for three months and the control group (CoG) did not use Carnitine. Serum levels of CRP and FBS were measured at baseline and at the end of the intervention. Statistical analysis was performed using the SPSS version 16.0. Results: the mean difference in CRP concentration in CaG and CoG were, 1.95 ±9.4 and 0.6±10.8 (μg/l), respectively (P-value=0.7) and the mean of FBS at the baseline and after 12 weeks in the CaG were 118.7±51.4 mg/dl and 110.1±48.2 mg/dl, respectively (P-value=0.3) and in the CoG were 142.8±88.7 mg/dl and 131.8±68.9 mg/dl (P-value=0.26). Conclusion: The oral administration of daily 1000 mg of L-carnitine for three months doesn’t effect on serum CRP and FBS concentrations in patients undergoing hemodialysis.
Full-Text [PDF 106 kb]   (1773 Downloads)    
Type of Study: Research | Subject: Special
Received: 2015/09/28 | Accepted: 2015/09/28 | Published: 2015/09/28

Add your comments about this article : Your username or Email:

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Iranian Journal of Diabetes and Obesity

Designed & Developed by : Yektaweb